“Mr. Wohlhauser is leaving the company on highly amicable terms,” Dr. Werner Müller, chairman of Evonik’s Supervisory Board, said. “Evonik has much to thank him for. Mr. Wohlhauser played a key role in shaping our chemicals operations over many years and most recently contributed to the successful bundling of our business in the segment structure. Dr. Kaufmann is a highly qualified successor who has known the company for many years as he has worked as consultant on a wide range of projects.”
Wohlhauser has been a member of the Executive Board of Evonik Industries AG since April 1, 2011 and took on responsibility for the chemical operations as COO on Jan. 1, 2014.
Dr. Kaufmann has been a managing partner of SCOPEIN Management Consultants in Düsseldorf (Germany) since 2001. In this period he has advised many companies in the chemical and pharmaceutical industry, including Evonik, on optimizing their operational efficiency and business portfolio. He started his career in corporate controlling at Henkel KGaA and subsequently worked as a project manager at the strategic management consultancy Droege & Comp. GmbH.